YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk cuts prices for Wegovy, Ozempic

Posted online

Novo Nordisk is cutting direct-to-consumer prices for weight loss drug Wegovy and diabetes counterpart Ozempic, CNBC reports.

The price of the drugs is dropping to $349 per month from $499 per month for existing cash-paying patients. The highest dose of Ozempic will remain at $499 per month.

Novo Nordisk also is launching a temporary introductory offer for the drugs. Patients can receive the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences